Clorox Reports Strong Q1 2027 Results Driven by GOJO Acquisition and Sales Growth
The Clorox Company (CLX) reported robust first-quarter results for fiscal year 2027, with net sales reaching $1.91 billion, a 33% increase year-over-year. This growth was significantly bolstered by the integration of GOJO and favorable comparisons against a prior period impacted by an ERP transition. Adjusted EPS rose 82% to $1.55, reflecting strong volume increases across Health and Wellness and Household segments. Despite top-line success, Clorox faces significant macroeconomic headwinds. The company updated its full-year gross margin guidance to 41.5% due to rising commodity, manufacturing, and logistics costs. Management noted that input cost inflation is projected at $240 million for the fiscal year—roughly 2.5 times higher than historical averages—driven by pressures in resin, energy, and transportation.
Topics: acquisition impact adjusted EPS financial guidance gross margin net sales growth
Read the full article at Motley Fool
Part of the story Clorox Reports Q1 Fiscal 2027 Results Amid Gojo Acquisition and ERP Transition (6 articles)